Syra Health Corp.
SYRA
$0.1043
-$0.0228-17.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 49.32% | -17.80% | -73.18% | -84.13% | -62.47% |
| Total Depreciation and Amortization | 346.42% | 418.28% | 300.00% | -66.97% | 328.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.37% | -94.72% | -19.42% | 136.63% | -428.39% |
| Change in Net Operating Assets | 132.44% | 1.02% | -220.92% | -18.44% | -7.56% |
| Cash from Operations | 87.78% | -11.91% | -155.79% | -1,675.39% | -43.85% |
| Capital Expenditure | -- | -- | 1.79% | 42.27% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 1.79% | 42.27% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 90.32% | 84.88% | -8,525.00% | 88.58% | -20.71% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 494.31% |
| Cash from Financing | -101.74% | 332.27% | -504.80% | 17.97% | 734.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.26% | 6,095.11% | -193.50% | -107.10% | 590.39% |